ABSTRACT
Statins are widely prescribed and the risk of adverse drug reactions of lipid-lowering therapy is actively discussed, including muscle symptoms. This review synthesizes the knowledge about the clinical aspects of statin-associated muscle symptoms, which is important for the practitioner. Potential mechanisms of their development, risk factors, clinical manifestations, treatment and prevention are described. Timely detection the side effects of statins makes it possible to diagnose and eliminate, which is crucial for conducting lipid-lowering therapy for patients with atherosclerotic cardiovascular diseases. Management of statin-associated muscle symptoms requires altering (reduced dosages, use of another statin or alternative lipid-lowering drugs) or discontinuing the statin treatment.
Subject(s)
Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Humans , Hypolipidemic Agents , Muscle, Skeletal , Risk FactorsABSTRACT
In recent years there has been a marked decrease in cardiac glycosides use in patients with heart failure in sinus rhythm and atrial fibrillation. The results of published studies contradict each other. Some of them doubt the favorable effect of digoxin in patients with heart failure; others refute the increase in the lethality and frequency of hospitalizations associated with the use of digoxin. In this regard, we found it important to analyze these reports impartially and reflect modern views on the mechanisms of cardiac glycosides, the pharmacokinetics and the possibility of optimizing digitalis therapy in cardiac practice.
Subject(s)
Atrial Fibrillation , Digitalis , Heart Failure , Digitalis Glycosides , Digoxin , HumansABSTRACT
Terra Populus, or TerraPop, is a cyberinfrastructure project that integrates, preserves, and disseminates massive data collections describing characteristics of the human population and environment over the last six decades. TerraPop has made a number of GIScience advances in the handling of big spatial data to make information interoperable between formats and across scientific communities. In this paper, we describe challenges of these data, or 'deserts in the deluge' of data, that are common to spatial big data more broadly, and explore computational solutions specific to microdata, raster, and vector data models.
ABSTRACT
UNLABELLED: The aim of this study was to evaluate the frequency and importance of anxiety and depression in patients with functional dyspepsia (FD), the relationship between these psychological characteristics, symptom severity and the quality of life. METHODS: We performed a cross-sectional study. 125 patients with FD according to the Rome criteria ill, as well as a control group of 30 healthy volunteers were investigated. All study participants filled out a scale to identify HADS anxiety-depressive disorder, an overall assessment of the quality of life, using a questionnaire SF-8 (standard 4-week form). FD patients were asked to rate the severity of epigastric pain (burning) or abdominal discomfort (early satiation or postprandial fullness) with LPDS scale (Leuven postprandial distress scale). All statistical analyzes were performed in the Medstat program. The results obtained with p < 0.05 and 95% CI were considered statistically significant. RESULTS: Anxiety and depression were observed in 50.4% and 42.4% of FD patients, respectively, and in 13.3% and 6.66% of healthy subjects, respectively (p < 0.001 for both). The mean HADS scores for anxiety and depression in lBS patients were 7.93 ± 3.75 and 6.94 ± 3.78, respectively. Both anxiety and depression were associated with self-reported symptom severity (LPDS) (p < 0.05). As determined by correlation analysis, symptom severity was the most important factor in the prediction of anxiety and depression. Self-reported symptom severity, anxiety and depression were clearly and independently associated with the overall health-related quality of life (HRQOL). CONCLUSIONS: Biopsychosocial model of FD explained the difficulties of the pathogenesis of this disease. Anxiety and de- pression were frequently observed in FD patients and were related to the severity of their symptoms and the impairment of the patient's HRQOL. Our data suggest that assessing anxiety and depression is important when evaluating FD patients.
Subject(s)
Abdominal Pain , Anxiety Disorders , Depressive Disorder , Dyspepsia , Quality of Life , Abdominal Pain/complications , Abdominal Pain/physiopathology , Abdominal Pain/psychology , Adolescent , Adult , Aged , Anxiety Disorders/complications , Anxiety Disorders/physiopathology , Anxiety Disorders/psychology , Depressive Disorder/complications , Depressive Disorder/physiopathology , Depressive Disorder/psychology , Dyspepsia/complications , Dyspepsia/physiopathology , Dyspepsia/psychology , Female , Humans , Male , Middle AgedABSTRACT
We have investigated 175 patients with Rome III diagnostic criteria for functional dyspepsia. 104 (59%) patients were infected with Helicobacter pylori. Three-component (PPI + clarithromycin + amoxicillin) 7-day therapy with the addition of the probiotic was effective in 92 patients (88.4%). Dyspeptic symptoms were resolved in 37 patients with successful eradication (40%). Persistent effect for 6 months was maintained in 24 patients (26%). Eradication efficacy in eliminating of the dyspepsia symptoms was higher in epigastric pain syndrome than postprandial distress syndrome.
Subject(s)
Abdominal Pain/drug therapy , Anti-Bacterial Agents/therapeutic use , Dyspepsia/drug therapy , Gastritis/drug therapy , Helicobacter Infections/drug therapy , Proton Pump Inhibitors/therapeutic use , Abdominal Pain/complications , Abdominal Pain/microbiology , Abdominal Pain/physiopathology , Adult , Amoxicillin/therapeutic use , Clarithromycin/therapeutic use , Drug Therapy, Combination , Dyspepsia/complications , Dyspepsia/microbiology , Dyspepsia/physiopathology , Female , Gastritis/complications , Gastritis/microbiology , Gastritis/physiopathology , Helicobacter Infections/complications , Helicobacter Infections/microbiology , Helicobacter Infections/physiopathology , Helicobacter pylori/drug effects , Helicobacter pylori/growth & development , Humans , Male , Probiotics/therapeutic use , Treatment OutcomeABSTRACT
PURPOSE: The aim of the current study was to evaluate an ultrasound approach for depicting elastic recovery after stem cell application on injured Achilles tendons. MATERIALS AND METHODS: A rabbit Achilles tendon injury model was used and randomized hind limbs received an extracellular matrix either with autologous mesenchymal stem cells (group 2, n = 6) or without (group 3, n = 6). The cells were harvested from the rabbits' nuchal fat body. Untreated Achilles tendons (group 1, n = 6) served as controls. Specimens were harvested after 8 weeks and analyzed longitudinally for elasticity using a high resolution 6-15 MHz matrix linear probe. For each tendon, real-time color-coded sonoelastography sequences were recorded for 20 seconds and 10 color histogram frames were obtained. Defined regions of interest (ROIs) were placed on the injury (n = 3) and on the adjacent uninjured tendon tissue (n = 3). In total, 180 measurements were obtained for semi-quantitative analysis. RESULTS: Repeated measures ANOVA demonstrated a higher elasticity for the stem cell-seeded matrix (group 2) in comparison to the unseeded matrix (group 3) (p < 0.001). No significant difference was found between the injured tendon tissue treated with stem cell-seeded matrix (group 2) and the uninjured Achilles tendons (group 1) (p > 0.05). Moreover, no differences were found between the measurements at different points in time (p > 0.05). CONCLUSION: Our results indicate that autologous mesenchymal stem cell application successfully restores the mechanical properties of injured tendon tissue. Furthermore, sonoelastography makes it possible to monitor the elasticity of injured Achilles tendons.
Subject(s)
Achilles Tendon/diagnostic imaging , Achilles Tendon/injuries , Disease Models, Animal , Elasticity Imaging Techniques/methods , Elasticity/physiology , Extracellular Matrix , Mesenchymal Stem Cell Transplantation , Tendon Injuries/diagnostic imaging , Tendon Injuries/therapy , Wound Healing/physiology , Achilles Tendon/pathology , Animals , Biomechanical Phenomena/physiology , Male , Rabbits , Tendon Injuries/pathologyABSTRACT
Ribosome biogenesis centres both physically and functionally on the activity of the ribosomal RNA (rRNA) genes. Ribosome assembly occurs co-transcriptionally on these genes, requires the coordinated expression and assembly of many hundreds of proteins and is finely tuned to cell and organism growth. This review presents contemporary understanding of the mode and the means of rRNA gene transcription and how growth factors, oncogenes and tumour suppressors regulate this transcription. It is argued that transcription elongation is a key mechanism regulating rRNA gene transcription. This unorthodox view provides a logical framework to explain the co-transcriptional phase of ribosome biogenesis.
Subject(s)
Gene Expression Regulation , Genes, rRNA , RNA, Ribosomal/biosynthesis , Ribosomes/metabolism , Animals , Base Sequence , Humans , Molecular Sequence Data , Protein Biosynthesis , RNA Polymerase I/metabolism , RNA, Ribosomal/chemistry , Ribosomes/genetics , Transcription, GeneticABSTRACT
Ribosome assembly occurs co-transcriptionally on the rRNA genes. This process requires the co-ordinated expression and assembly of many hundreds of proteins and is finely tuned to cell and organism growth. Co-ordinate regulation of the rRNA genes and the ribosomal protein genes is therefore essential for high-fidelity ribosome assembly. Recent work shows that rRNA gene transcription is regulated at the level of elongation via the mitogen-activated protein kinase pathway. We argue that this may provide an explanation for the high fidelity of ribosome assembly.
Subject(s)
RNA, Ribosomal/genetics , Animals , DNA-Directed RNA Polymerases/genetics , Gene Expression Regulation , Growth Substances/physiology , Mammals , Models, Genetic , Models, Molecular , RNA, Ribosomal/chemistry , Transcription, GeneticABSTRACT
Ribosomal transcription in mammals is regulated in response to growth, differentiation, disease, and aging, but the mechanisms of this regulation have remained unresolved. We show that epidermal growth factor induces immediate, ERK1/2-dependent activation of endogenous ribosomal transcription, while inactivation of ERK1/2 causes an equally immediate reversion to the basal transcription level. ERK1/2 was found to phosphorylate the architectural transcription factor UBF at amino acids 117 and 201 within HMG boxes 1 and 2, preventing their interaction with DNA. Mutation of these sites inhibited transcription activation and abrogated the transcriptional response to ERK1/2. Thus, growth factor regulation of ribosomal transcription likely acts by a cyclic modulation of DNA architecture. The data suggest a central role for ribosome biogenesis in growth regulation.